Somatic genetic alterations in human malignant mesothelioma (Review)

International Journal of Oncology

Volumn 14, Issue 1, 1999, Pages 181-188

  Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Chromosome abnormalities; Loss of heterozygosity; Mesothelioma; NF2; P16; Tumor suppressor genes

Indexed keywords

CHROMOSOME ABERRATION; GENETICS; HUMAN; KARYOTYPING; MESOTHELIOMA; REVIEW; TUMOR SUPPRESSOR GENE;

CHROMOSOME ABERRATIONS; GENES, NEUROFIBROMATOSIS 2; GENES, P16; HUMANS; KARYOTYPING; MESOTHELIOMA;

EID: 0032615070     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Antman KH: Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol 8: 313-320, 1981.
2. McDonald JC and McDonald AD: The epidemiology of mesothelioma in historical context. Eur Respiratory J 9: 1932-1942, 1996.
3. Attanoos RL and Gibbs AR: Pathology of malignant mesothelioma. Histopathology 30: 403-418, 1997.